Atlas Trials

Safety and Efficacy of Two Different Concentrations (0.5% and 1%) of Progesterone Topical Gel Compared to Placebo in Patients Diagnosed With Moderate to Severe Dry Eye Syndrome

Clinical trial NCT04645446 · COMPLETED

Trial details

NCT number
NCT04645446
Sponsor
SIFI SpA
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dry Eye Disease
Start date
2021-02-18
Primary completion
2022-10-27
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.